Severe non-infectious secondary effects of blood transfusion;Complicaciones no infecciosas graves de la transfusión

Medicina Clinica

Volumn 119, Issue 14, 2002, Pages 550-554

  Lozano Molero, Miguel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acute hemolytic reaction; Blood transfusion; Graft versus host disease; Non infectious hazards; Transfusion related acute lung injury.

Indexed keywords

BLOOD COMPONENT; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION REACTION; DISEASE SEVERITY; ERROR; GENETIC VARIABILITY; HEPATITIS; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; INCIDENCE; LUNG INJURY; MORTALITY; REVIEW; TREATMENT INDICATION;

EID: 18244425052     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)73489-1     Document Type: Review

References (57)

1. Mannucci PM. Clinical evaluation of viral safety of coagulation factor- VIII and factor-IX concentrates. Vox Sang 1993;64:197-203.
2. Williamson LM, Allain JP. Virally inactivated fresh frozen plasma. Vox Sang 1995;69:159-65.
3. Bopp MKF, Morell A, Indrak K, Parkkinen J, Mertens H, Mohr H, et al. Pathogen inactivation of labile blood products. Transfus Med 2001;11:149-75.
4. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Medical progress - Transfusion medicine (First of two parts). Blood transfusion. N Engl J Med 1999;340:438-47.
5. Robillard P, Blouin N, Hache D. Adverse transfusion reactions: experience of the Quebec hemovigilance system. Transfusion 2000;40(Suppl 1): 134.
6. Love EM, Jones H, Williamson LM, Cohen H, Todd A, Soldan K et al. Four years of the serious hazards of transfusion (SHOT) scheme in the UK. 1997-2000. Actas de la Jornada sobre Hemovigilancia. Madrid: Ministerio de Sanidad y Consumo, 27 de febrero de 2002.
7. Linden JV. Errors in transfusion medicine -scope of the problem. Arch Pathol Lab Med 1999;123:563-5.
8. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, Mcclelland DBL, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 1999;319:16-9.
9. Callum JL, Kaplan HS, Merkley LL, Pinkerton PH, Fastman BR, Romans RA, et al. Reporting of near-miss events for transfusion medicine: improving transfusion safety. Transfusion 2001;41:1204-11.
10. Linden JV Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992;32:601-6.
11. Lassale B, Clement S, Fourgnaud-Gaillard S, Malinvaud G. Accidents hémolytiques transfusionnels par incompatibilité ABO Rh. Responsabilité médicale. Presse Med 1993;22:565.
12. Honig CL, Bove JR. Transfusion-associated fatalities: review of Bureau of Biologics reports 1976-1978. Transfusion 1980;20:653-61.
13. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990;30:583-90.
14. Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 2000;40:1207-13.
15. US Food and Drug Administration. Workshop on best practices for reducing transfusion errors. Bethesda (Maryland): February 14, 2002. Las transcripciones de las conferencias están disponibles en: http://www.fda.gov/cber/minutes/0214bloo.pdf
16. Taswell HF, Galbreath JL, Harmsen WS. Errors in Transfusion Medicine -detection, analysis, frequency, and prevention. Arch Pathol Lab Med 1994;118:405-10.
17. Wenz B, Mercuriali F, AuBuchon JP. Practical methods to improve transfusion safety by using novel blood unit and patient identification systems. Am J Clin Pathol 1997;107:S12-S6.
18. Mercuriali F, Inghilleri G, Colotti MT, Fare M, Biffi E, Vinci A, et al. Bedside transfusion errors; analysis of 2 years' use of a system to monitor and prevent transfusion errors. Vox Sang 1996;70:16-20.
19. Pierce RN, Reich LM, Mayer K. Hemolysis following platelet transfusions from ABO-incompatible donors. Transfusion 1985;25:60-2.
20. Murphy MF, Wilkinson J, Lowe D, Pearson M. National audit of the blood transfusion process in the UK. Transfus Med 2001;11:363-70.
21. Jeter EK, Spivey MA. Noninfectious complications of blood transfusion. Hematol Oncol Clin N Amer 1995;9:187-204.
22. Nussbaumer W, Schwaighofer H, Gratwohl A, Kilga S, Schonitzer D, Nachbaur D, et al. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility. Transfusion 1995;35:592-5.
23. Davenport RD. Management of transfusion reactions. En: Mintz PD, editor. Transfusion therapy: clinical principles and practice. Bethesda: AABB Press, 1999; p. 359-78.
24. Popovsky MA, Moore SB. Diagnostic and pathogenic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-7.
25. Kopko PM, Holland PV. Transfusion-related acute lung injury. Br J Haematol 1999;105:322-9.
26. Silliman CC. Transfusion-related acute lung injury. Transfus Med Rev 1999;13:177-86.
27. Rizk A, Gorson KC, Kenney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 2001;41:264-8.
28. Silliman CC, Paterson AJ, Dickey WO, Stroncek DF, Popovsky MA, Caldwell SA, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997;37:719-26.
29. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968-71.
30. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998;101:1458-67.
31. Win N, Montgomery J, Sage D, Street M, Duncan J, Lucas G. Recurrent transfusion-related acute lung injury. Transfusion 2001;41:1421-5.
32. McCullough J, Clay M, Hurd D, Richards K, Ludvigsen C, Forstrom L. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes. Blood 1986;67:522-8.
33. Lenahan SE, Domen RE, Silliman CC, Kingsley CP, Romano PJ. Transfusion-related acute lung injury secondary to biologically active mediators. Arch Pathol Lab Med 2001;125:523-6.
34. Popovsky MA, Davenport RD. Transfusion-related acute lung injury: femme fatale? Transfusion 2001;41:312-5.
35. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion 2001;41:1244-8.
36. Flesch BK, Neppert J. Transfusion-related acute lung injury caused by human leucocyte antigen class II antibody. Br J Haematol 2002; 116:673-6.
37. Fast LD, Valeri CR, Crowley JP. Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F-1 hybrid recipients: implications for transfusion-associated graft-versus-host disease. Blood 1995;86:3090-6.
38. Brubaker DB. Pathogenesis and diagnosis of posttransfusion graft-vs-host disease. En: Baldwin ML, Jefferies LC, editors. Irradiation of blood components. Bethesda: American Association of Blood Banks, 1992; p. 1-30.
39. Wagner FF, Flegel WA. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion 1995;35:284-91.
40. Asai T, Inaba S, Ohto H, Osada K, Suzuki G, Takahashi K, et al. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan. Transfusion Mad 2000;10:315-20.
41. Takahashi K, Juji T, Miyamoto M, Uchida S, Akaza T, Tadokoro K, et al. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Lancet 1994;343:700-2.
42. Von Fliedner V, Higby DJ, Kim U. Graft versus host reaction following blood product transfusion. Am J Med 1982;79:951-961.
43. Park BH, Good RA, Gate J, Burke B. Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease. Transplant Proc 1974;6:385-7.
44. Williamson LM. Transfusion associated graft versus host disease and its prevention. Heart 1998;80:211-2.
45. Sakurai M, Moizumi Y, Uchida S, Imai Y, Tabayashi K. Transfusion-associated graft-versus-host disease in immunocompetent patient: early diagnosis and therapy. Am J Hematol 1998;58:84-6.
46. Perrotta PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev 2001;15:69-83.
47. Nishimura H, Alkaza T, Tadokoro K, Juji T. Potential usefulness of protease inhibitor and chloroquine in the treatment of transfusion-associated graft-versus-host disease. Transfusion 1997;37:768-770.
48. Nishimura M, Akaza T, Tadokoro K, Juji T. Potential usefulness of photochemotherapy using 8-methoxypsoralen in the treatment of posttransfusion graft-versus-host disease. Vox Sang 1998;75:306-307.
49. Ryo R, Saigo K, Hashimoto M, Kohsaki M, Yasufuku M, Watanabe N, et al. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. Vox Sang 1999;76:241-6.
50. Juji T, Nishimura M, Tadokoro K. Treatment of post transfusion graft-versus-host disease. Vox Sang 2000;78(Suppl 2):277-9.
51. Moroff G, Leitman SF, Luban NLC. Principles of blood irradiation, dose validation, and quality control. Transfusion 1997;37:1084-1092.
52. Guide to the preparation, use and quality assurance of blood components. 7th ed. Strasburg: Council of Europe Publishing, 2001.
53. Williamson LM. British Committee for Standards in Haematology Blood Transfusion Task Force: guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfus Med 1996;6:261-71.
54. Anderson KC. Clinical indications for blood component irradiation. En: Baldwin ML, Jefferies LC, editors. Irradiation of blood components. Bethesda: American Association of Blood Banks, 1992; p. 31-49.
55. Przepiorka D, LeParc GF, Stovall MA, Werch J, Lichtiger B. Use of irradiated blood components: Practice parameter. Am J Clin Pathol 1996; 106:6-11.
56. Grass JA, Wafa T, Reames A, Wages D, Corash L, Ferrara JLM, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999;93:3140-7.
57. Finucane ML, Slovic P, Mertz CK. Public perception of the risk of blood transfusion. Transfusion 2000;40:1017-22.